Trials / Completed
CompletedNCT02618369
MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Pain Management of Osteoid Osteoma and Benign Bone Tumors in Children and Young Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- The Hospital for Sick Children · Academic / Other
- Sex
- All
- Age
- 5 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The Philips Sonalleve HIFU system is expected to be efficacious in reducing pain scores in patients with painful osteoid osteoma and other benign bone tumors, and in reducing their pain medication usage. No serious adverse effects are expected to result from this treatment.
Detailed description
The objective of this study is to determine if MR-guided high-intensity focused ultrasound (MR-HIFU) is safe and effective technique for alleviating the pain associated with osteoid osteoma and other benign bone tumors in paediatric patients and adults(up to age 40 yrs). This technique meant to be an alternative to the standard-of-care, radiofrequency and laser-based percutaneous ablation. Safety of the technique will be assessed through evaluating non-targeted heating using MRI based temperature mapping. and inspecting patients post treatment for skin burns or other signs of serious adverse events. Efficacy of the technique will be assessed by evaluating/recording patients observed pain, quality of life, and pain medication usage both before and up to 6 months following treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MR-Guided High Intensity Focused Ultrasound | Target treatment of bone lesion using High Intensity Focused Ultrasound |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-04-01
- Completion
- 2018-10-01
- First posted
- 2015-12-01
- Last updated
- 2024-05-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02618369. Inclusion in this directory is not an endorsement.